GENZYME CORP. et al v. ZENARA PHARMA PRIVATE LIMITED > Summary
Court Case Number 3:19-cv-05160
Filing Date Feb 8, 2019
Termination Date Feb 28, 2019
Court New Jersey District Court
Status Dismissed - Voluntarily
Defendant
Plaintiff Attorneys
12Sanofi
Attorney Name: Katelyn O'Reilly
Walsh Pizzi O’Reilly Falanga LLP
Sanofi
Attorney Name: Liza M. Walsh
Walsh Pizzi O’Reilly Falanga LLP
The Regents Of The University Of Michigan
Attorney Name: Katelyn O'Reilly
Walsh Pizzi O’Reilly Falanga LLP
The Regents Of The University Of Michigan
Attorney Name: Liza M. Walsh
Walsh Pizzi O’Reilly Falanga LLP
Sanofi Genzyme
Attorney Name: William E. Solander
Venable
Sanofi Genzyme
Attorney Name: Daniel J. Minion
Venable
Sanofi Genzyme
Attorney Name: Damien N. Dombrowski
Venable
Sanofi Genzyme
Attorney Name: Katherine E. Adams
Venable
The Regents Of The University Of Michigan
Attorney Name: William E. Solander
Venable
The Regents Of The University Of Michigan
Attorney Name: Daniel J. Minion
Venable
The Regents Of The University Of Michigan
Attorney Name: Damien N. Dombrowski
Venable
The Regents Of The University Of Michigan
Attorney Name: Katherine E. Adams
Venable
Cause
35:271 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
07615573 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | Nov 10, 2009 |
07253185 | Amino ceramide-like compounds and therapeutic methods of use | Aug 7, 2007 |
07196205 | Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors | Mar 27, 2007 |
06916802 | Amino ceramide-like compounds and therapeutic methods of use | Jul 12, 2005 |